Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM192A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TOR1AIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IDH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM165 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL2RG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00265 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C22orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC31A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIVEP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on